Skip to content

Contact

FIP Non-communicable diseases

Transforming pharmacy practice to beat NCDs

About
Main NCD Areas
Cancer Cardiovascular diseases Chronic disease care Chronic kidney disease Chronic respiratory diseases Diabetes Erectile dysfunction Mental health
NCD risk factors
Air Pollution Alcohol consumption Nutrition and weight management Physical inactivity Sleep management Stress management Tobacco use
Other NCD Resources
Publications Digital Events Partnerships Groups and networks
Practice Transformation Programme
Publications Digital Events Partnerships

Aspartyl (Asparaginyl)-Beta-Hydroxylase (ASPH) inhibitors for the treatment of cancer

Aspartyl (Asparaginyl)-Beta-Hydroxylase (ASPH) inhibitors for the treatment of cancer

Post navigation

Pharmacists supporting men with erectile dysfunction: A people-centred approach to care

Pharmacists at the Frontline: Tackling NCDs Together – Coffee with FIP Episode 1

Follow us

We work with

Partnerships
FIP
FIP partners

Shortcuts

About
Main NCD areas
NCD risk factors
Other NCD resources
Practice Transformation Programme

Our contact details FIP NCD Programme
Andries Bickerweg 5
2517 JP The Hague
Netherlands

E: [email protected]

© Copyright International Pharmaceutical Federation 2025

Privacy statement
Disclaimer
Scroll to top